Analyst Reco. Thermo Fisher Scientific, Inc.

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:02 2025-12-16 pm EST			5-day change	1st Jan Change
570.16 ^USD	-1.00%		+0.34%	+9.60%

Dec. 15	Wells Fargo Adjusts PT on Thermo Fisher Scientific to $675 From $635, Maintains Overweight Rating	MT
Dec. 15	Thermo Fisher Scientific Expands Gibco?? Bacto?? Portfolio with Next-Generation, Chemically Defined Media to Boost E. Coli Biomanufacturing Productivity	CI

Analyst Reco.

Wells Fargo Adjusts PT on Thermo Fisher Scientific to $675 From $635, Maintains Overweight Rating	Dec. 15	MT
Citigroup Upgrades Thermo Fisher Scientific to Buy From Neutral, Adjusts PT to $660 From $580	Dec. 11	MT
Analyst recommendations: 3M Company, Exxon Mobil, Mastercard, Netflix, Tesla…	Dec. 08
KeyBanc Upgrades Thermo Fisher Scientific to Overweight From Sector Weight, Price Target is $750	Dec. 08	MT
Morgan Stanley Raises Price Target on Thermo Fisher Scientific to $670 From $656, Keeps Overweight Rating	Dec. 02	MT
Analyst recommendations: Chevron, Crown Castle, Old Dominion, AMD, DraftKings…	Dec. 01
HSBC Upgrades Thermo Fisher Scientific to Buy From Hold, Adjusts Price Target to $670 From $550	Dec. 01	MT
Thermo Fisher Scientific Says US FDA Clears Exent System for Multiple Myeloma Diagnosis	Nov. 12	MT
Argus Research Adjusts Thermo Fisher Scientific Price Target to $610 From $580	Oct. 29	MT
Morgan Stanley Raises Price Target on Thermo Fisher Scientific to $656 From $560, Keeps Overweight Rating	Oct. 28	MT
UBS Adjusts Thermo Fisher Scientific Price Target to $590 From $500, Maintains Neutral Rating	Oct. 23	MT
HSBC Adjusts Price Target on Thermo Fisher Scientific to $550 From $510, Maintains Hold Rating	Oct. 23	MT
JPMorgan Adjusts PT on Thermo Fisher Scientific to $675 From $650, Maintains Overweight Rating	Oct. 23	MT
Barclays Adjusts PT on Thermo Fisher Scientific to $625 From $585, Maintains Overweight Rating	Oct. 23	MT
TD Cowen Adjusts Price Target on Thermo Fisher Scientific to $654 From $612, Maintains Buy Rating	Oct. 23	MT
Citigroup Adjusts Price Target on Thermo Fisher Scientific to $580 From $500, Maintains Neutral Rating	Oct. 23	MT
Jefferies Adjusts Price Target on Thermo Fisher Scientific to $650 From $560, Maintains Buy Rating	Oct. 23	MT
Deutsche Bank Adjusts Price Target on Thermo Fisher Scientific to $620 From $530, Maintains Buy Rating	Oct. 23	MT
Leerink Partners Adjusts PT on Thermo Fisher Scientific to $580 From $545, Maintains Outperform Rating	Oct. 23	MT
Wells Fargo Adjusts PT on Thermo Fisher Scientific to $635 From $565, Maintains Overweight Rating	Oct. 23	MT
Wolfe Research Adjusts PT on Thermo Fisher Scientific to $615 From $525, Maintains Outperform Rating	Oct. 23	MT
Baird Adjusts Price Target on Thermo Fisher Scientific to $645 From $628, Maintains Outperform Rating	Oct. 23	MT
Raymond James Adjusts PT on Thermo Fisher Scientific to $630 From $535, Maintains Outperform Rating	Oct. 23	MT
Wolfe Research Raises Price Target on Thermo Fisher Scientific to $615 From $525	Oct. 22	MT
Leerink Partners Raises Price Target on Thermo Fisher Scientific to $580 From $545	Oct. 22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Thermo Fisher opens the biotech ball with a bang

July 25, 2024 at 10:56 am EDT